Recent advances in amyotrophic lateral sclerosis

Research output: Contribution to journalReview article

Abstract

ALS is a relentlessly progressive and fatal disease, with no curative therapies available to date. Symptomatic and palliative care, provided in a multidisciplinary context, still remains the cornerstone of ALS management. However, our understanding of the molecular mechanisms underlying the disease has advanced greatly over the past years, giving new hope for the development of novel diagnostic and therapeutic approaches. Here, we have reviewed the most recent studies that have contributed to improving both clinical management and our understanding of ALS pathogenesis.
Original languageEnglish
Pages (from-to)1241 - 1254
Number of pages14
JournalJournal of Neurology
Volume263
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

Fingerprint

Amyotrophic Lateral Sclerosis
Palliative Care
Therapeutics

Keywords

  • ALS genetics
  • Clinical management
  • Motor neuron disease
  • Neuroimaging
  • Pathogenesis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Recent advances in amyotrophic lateral sclerosis. / Riva, Nilo; Agosta, Federica; Lunetta, Christian; Filippi, Massimo; Quattrini, Angelo.

In: Journal of Neurology, Vol. 263, No. 6, 01.06.2016, p. 1241 - 1254.

Research output: Contribution to journalReview article

@article{0f87eb11515c4eb3916895dbc34ddd1a,
title = "Recent advances in amyotrophic lateral sclerosis",
abstract = "ALS is a relentlessly progressive and fatal disease, with no curative therapies available to date. Symptomatic and palliative care, provided in a multidisciplinary context, still remains the cornerstone of ALS management. However, our understanding of the molecular mechanisms underlying the disease has advanced greatly over the past years, giving new hope for the development of novel diagnostic and therapeutic approaches. Here, we have reviewed the most recent studies that have contributed to improving both clinical management and our understanding of ALS pathogenesis.",
keywords = "ALS genetics, Clinical management, Motor neuron disease, Neuroimaging, Pathogenesis",
author = "Nilo Riva and Federica Agosta and Christian Lunetta and Massimo Filippi and Angelo Quattrini",
year = "2016",
month = "6",
day = "1",
doi = "10.1007/s00415-016-8091-6",
language = "English",
volume = "263",
pages = "1241 -- 1254",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "6",

}

TY - JOUR

T1 - Recent advances in amyotrophic lateral sclerosis

AU - Riva, Nilo

AU - Agosta, Federica

AU - Lunetta, Christian

AU - Filippi, Massimo

AU - Quattrini, Angelo

PY - 2016/6/1

Y1 - 2016/6/1

N2 - ALS is a relentlessly progressive and fatal disease, with no curative therapies available to date. Symptomatic and palliative care, provided in a multidisciplinary context, still remains the cornerstone of ALS management. However, our understanding of the molecular mechanisms underlying the disease has advanced greatly over the past years, giving new hope for the development of novel diagnostic and therapeutic approaches. Here, we have reviewed the most recent studies that have contributed to improving both clinical management and our understanding of ALS pathogenesis.

AB - ALS is a relentlessly progressive and fatal disease, with no curative therapies available to date. Symptomatic and palliative care, provided in a multidisciplinary context, still remains the cornerstone of ALS management. However, our understanding of the molecular mechanisms underlying the disease has advanced greatly over the past years, giving new hope for the development of novel diagnostic and therapeutic approaches. Here, we have reviewed the most recent studies that have contributed to improving both clinical management and our understanding of ALS pathogenesis.

KW - ALS genetics

KW - Clinical management

KW - Motor neuron disease

KW - Neuroimaging

KW - Pathogenesis

UR - http://www.scopus.com/inward/record.url?scp=84962263911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962263911&partnerID=8YFLogxK

U2 - 10.1007/s00415-016-8091-6

DO - 10.1007/s00415-016-8091-6

M3 - Review article

VL - 263

SP - 1241

EP - 1254

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 6

ER -